Literature DB >> 16944410

Review of deaths related to analgesic- and cough suppressant-opioids; England and Wales 1996-2002.

F Schifano1, G Zamparutti, F Zambello, A Oyefeso, P Deluca, M Balestrieri, D Little, A H Ghodse.   

Abstract

OBJECTIVE: The data on England and Wales voluntarily supplied by Coroners to the National Programme on Substance Abuse Deaths for the August 1996-December 2002 time frame were analyzed.
METHODS: All cases in which at least one analgesic- and cough suppressant-opioid other than heroin/morphine, methadone or buprenorphine was identified were extracted from the database. We hypothesized that: a) populations of addicts and non-addicts presented differences in patterns of drugs involved; and b) within the population of addicts and non-addicts, intentional and non-intentional deaths presented different patterns of substance consumption.
RESULTS: A total of 2024 deaths related to selected opioids, either alone or in combination, were included in the analysis. Typically, non-addicts were older than 45 and died as a result of intentional poisoning whilst majority of addicts were young, males and victims of accidental deaths. In about 93% of cases the selected opioids were reported in combination with another substance. Most frequently identified narcotics were propoxyphene, codeine and dihydrocodeine. Co-proxamol, Co-codamol and Co-dydramol were typically prescribed for non-addicts, whilst dihydrocodeine was mostly given to addicts. In non-addicts, alcohol was mostly represented in accidental deaths and antidepressants were typically represented in intentional deaths. Conversely, illicit drugs and hypnotics/sedatives were typically reported in addicts' accidental deaths.
CONCLUSIONS: The present report constitutes the largest available collection of analgesic- and cough suppressant-opioid mortality data in the UK. Users should be educated about risks associated with polydrug misuse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944410     DOI: 10.1055/s-2006-949149

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  5 in total

1.  A procedure that differentiates unintentional from intentional overdose in opioid abusers.

Authors:  Peter C Britton; Amy S B Bohnert; James D Wines; Kenneth R Conner
Journal:  Addict Behav       Date:  2011-09-02       Impact factor: 3.913

2.  Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

Authors:  Giuliano Zamparutti; Fabrizio Schifano; John M Corkery; Adenekan Oyefeso; A Hamid Ghodse
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

3.  Opioid microinjection into raphe magnus modulates cardiorespiratory function in mice and rats.

Authors:  Kevin M Hellman; Scott J Mendelson; Marco A Mendez-Duarte; James L Russell; Peggy Mason
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-26       Impact factor: 3.619

4.  Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013-2019: A Retrospective Observational Study.

Authors:  Georgia C Richards; Jeffrey K Aronson; Brian MacKenna; Ben Goldacre; F D Richard Hobbs; Carl Heneghan
Journal:  Drug Saf       Date:  2022-01-22       Impact factor: 5.606

5.  Always consider the possibility of opioid induced respiratory depression in patients presenting with hypercapnic respiratory failure who fail to improve as expected with appropriate therapy.

Authors:  Martin Steynor; Andrew MacDuff
Journal:  Case Rep Crit Care       Date:  2015-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.